— Know what they know.
Not Investment Advice

ADVB NASDAQ

Advanced Biomed Inc. Common Stock
1W: +5.5% 1M: -31.1% 3M: +32.5% YTD: +11.4% 1Y: -24.9%
$6.73
-0.18 (-2.60%)
 
Weekly Expected Move ±11.1%
$5 $6 $7 $7 $8
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 38 · $9.3M mcap · 561307 float · 257.55% daily turnover · Short 47% of daily vol

Supply Chain Overview

4 relationships
4
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2025-06-06
Earliest Filing
2026-04-03
Latest Filing
target: 2 acquirer: 1 investor: 1

Counterparties (Filed by ADVB)

4 relationships

Companies named in ADVB's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Acellent Technologies (Hong Kong) Co. Limited — target Target company acquired 100% of its equity interest by Advanced Biomed Inc. for 270,000 shares. 2026-04-03 View
Advanced Biomed (HK) Limited ADVB target Wholly owned subsidiary of the Company sold in a spin-off transaction 2026-01-27 View
Wei Ha Hui — acquirer Unrelated third party purchasing 100% of Advanced Biomed (HK) Limited 2026-01-27 View
HELENA GLOBAL INVESTMENT OPPORTUNITIES I LTD. — investor Investor in a purchase agreement for up to $25,000,000 of the Company's common stock. 2025-06-06 View
Recent 8-K Filings (19)
Filing Date Description Type SEC
2026-07-17 Termination of Agreement; Exhibits View
2026-07-01 Shareholder Vote View
2026-06-30 Material Agreement; Exhibits Agreement View
2026-05-01 Acquisition/Disposition; Unregistered Equity Sales; Officer/Director Change; Exhibits Acquisition View
2026-04-14 Material Agreement; Exhibits Agreement View
2026-04-03 Material Agreement; Exhibits Agreement View
2026-03-30 Officer/Director Change View
2026-03-16 Other Events View
2026-02-26 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2026-02-10 Unregistered Sales of Equity Securities View
2026-02-02 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2026-01-27 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2026-01-21 Notice of Delisting or Transfer View
2025-12-30 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regula Agreement Acquisition View
2025-09-19 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-07-24 Notice of Delisting or Transfer View
2025-06-06 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-05-28 Departure/Election of Directors; Appointment of Officers View
2025-03-10 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms